icon-folder.gif   Conference Reports for NATAP  
61th Annual Meeting of the American Association for the Study of Liver Diseases
Boston, MA, Hynes Convention Center
October 30-November 3, 2010
Back grey_arrow_rt.gif
In vitro studies investigating the mechanism of interaction between TMC435 and hepatic transporters
  Reported by Jules Levin
AASLD Nov 2 Boston
M. T. Huisman,1 J. Snoeys,1 J. Monbaliu,1 M. Martens,2 V. Sekar,3 A. Raoof4 1Janssen Pharmaceutical Companies of Johnson & Johnson, Research and Development, Beerse, Belgium; 2Formerly Tibotec, Beerse, Belgium; 3Tibotec Inc., Titusville, NJ, USA; 4Tibotec, Beerse, Belgium Disclosure: MTH, JS, and JM are employees of Janssen Pharmaceutical Companies of Johnson & Johnson. VS and AR are employees of Tibotec.